NON-COMPETE AGREEMENTNon-Compete Agreement • October 4th, 2023 • Invea Therapeutics, Inc • Pharmaceutical preparations • New York
THIS NON-COMPETE AGREEMENT (the “Agreement”) is made and entered into as of September 19, 2023 (the “Effective Date”), by and among BioXcel Therapeutics, Inc. (“BTAI”), a Delaware corporation, BioXcel LLC (“BioXcel LLC”), a Delaware limited liability company, BioXcel Holdings, Inc., a Delaware corporation (“Holdings”), Dr. Krishnan Nandabalan, InveniAI LLC (“InveniAI”), a Delaware limited liability company, and Invea Therapeutics, Inc. (“Invea”), a Delaware corporation (collectively, the “Parties” and each referred to as a “Party”).
AlphaMeld® License Agreement between Invea Therapeutics, INC. Guilford, CT, 06437 (hereinafter referred to as “Invea”) and InveniAI LLC, Guilford, CT, 06437 Effective Date: October 1’2023 (hereinafter referred to as “InveniAI”) (hereinafter called the...® License Agreement • October 4th, 2023 • Invea Therapeutics, Inc • Pharmaceutical preparations
This AlphaMeld® License Agreement is made by and between Invea and InveniAI on the Effective Date identified above (the “Effective Date”). Appendix A (AlphaMeld License Terms) and Appendix B (Support Policy) are hereby incorporated by reference in their entirety. In the event of a conflict between the AlphaMeld License Terms and the remainder of this Agreement, the remainder of this Agreement shall control.
